Movember Team Grants
Prostate Cancer Canada is proud to offer its annual Movember Team Grants program, awarding funding to collaborative and innovative research teams in t
he field of prostate cancer. The goal of the Movember Team Grants program is to support trans-Canadian research teams, providing an increasingly united approach to prostate cancer research.
Reviewed by an international committee of prostate cancer experts, Team Grants are awarded to proposals that apply a multidisciplinary approach to answer a specific question in prostate cancer. Proposed research can come from any stream of prostate cancer research, including prostate cancer biology, treatment, diagnosis, survivorship and prevention.
The program brings together Canadian experts to pool their expertise and focus on a specific topic, while also providing a training environment for investigators just starting their research careers, such as fellows, graduate and undergraduate students and others from a multidisciplinary environment.
Successful applicants will receive funding provided to a maximum of five years. To review the full Request for Applications, please click here
The budget envelope is set for this program; however, the ultimate number of grants awarded will depend on the quality of submissions as determined during the review process. This may result in the final funding for this competition being greater than the currently budgeted $10M. There is no yearly maximum; however, budget requests must average $1M/year over the term of the grant for up to five years; e.g. 5 years=$5M, 3 years =$3M.
If you are seeking clarifications, please refer to the FAQs prior to contacting PCC. The FAQs
document will continue to be updated as questions are put forward.
PCC would like to recognize the Movember Foundation as an important funder of this program, providing the opportunity to support effective and efficient Canadian collaboration in the field of prostate cancer research.
For this team grant competition, the Expressions of Interest (EOIs) will be evaluated based on their excellence as judged against the following criteria:
Overall objective and extent of innovation of the program of research
Significance of research on our understanding of prostate cancer
Successful applicants will be invited to submit a full application.